Loss of LCMT1 and Biased Protein Phosphatase 2A Heterotrimerization Drive Prostate Cancer Progression and Therapy Resistance

Scientists reported that the leucine carboxy methyltransferase (LCMT1), which methylated the L309 residue of the C subunit, acted as a suppressor of androgen receptor addicted prostate cancer.